Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine as Neoadjuvant Therapy in Locally Advanced Breast Cancer
NCT00347438Phase 2Terminated
- Sponsor
- University of Chicago
- Start
- Sep 2006
- Primary completion
- Mar 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of capecitabine in breast cancer, sponsored by University of Chicago. Started Sep 2006; status: terminated.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00347438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347438.